M. Paraire

Efficacy and safety of rilmenidine for arterial hypertension.

S. Laurin, F. Mahieux, B. Beau, 1988, The American journal of cardiology.

Early monitoring of human renal transplantations by N-acetyl-beta-D-glucosaminidase isoenzyme activities in urines.

R. Bourbouze, P. Frantz, J. Luciani, 1985, Clinica chimica acta; international journal of clinical chemistry.

Differential assay of A and B isoenzymes in urinary N-acetyl-β-d-glucosaminidase

R. Bourbouze, F. Percheron, F. Baumann, 1983 .

Complete bioavailability and lack of food‐effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers

R Jochemsen, M Paraire, R. Jochemsen, 2002, Biopharmaceutics & drug disposition.

Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation.

N. Holford, N. Frey, Roeline Jochemsen, 2003, British journal of clinical pharmacology.

Effects of the new nitrosourea derivative, fotemustine, on the glutathione reductase activity in rat tissues in vivo and in isolated rat hepatocytes.

J. Boutin, P. Moldéus, G. Lavielle, 1989, European journal of cancer & clinical oncology.

Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.

A. Laquérriere, G. Raguenez-Viotte, J. Hemet, 1991, European journal of cancer.

Complete Bioavailability and Lack of Food-effect on Pharmacokinetics of Gliclazide 30mg Modified Release in Healthy Volunteers

R. Jochemsen, P. Delrat, M. Paraire, 2002 .